Chuangyan Wu

888 total citations
37 papers, 675 citations indexed

About

Chuangyan Wu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Chuangyan Wu has authored 37 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Chuangyan Wu's work include MicroRNA in disease regulation (8 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (5 papers). Chuangyan Wu is often cited by papers focused on MicroRNA in disease regulation (8 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (5 papers). Chuangyan Wu collaborates with scholars based in China and United States. Chuangyan Wu's co-authors include Sihua Wang, Song Tong, Jiuling Chen, Xiangchao Ding, Jie Wu, Anchen Zhang, Xiaofan Huang, Yu Yuan, Jinjun Jiang and Su Yuan and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Chuangyan Wu

33 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuangyan Wu China 15 343 177 118 111 101 37 675
Yanxian Lai China 13 224 0.7× 140 0.8× 86 0.7× 132 1.2× 133 1.3× 35 679
Marco Benati Italy 15 286 0.8× 221 1.2× 49 0.4× 43 0.4× 103 1.0× 36 697
Ziyun Shao China 10 358 1.0× 220 1.2× 64 0.5× 45 0.4× 111 1.1× 13 593
Yanjia Chen China 15 376 1.1× 93 0.5× 98 0.8× 48 0.4× 97 1.0× 37 811
Hong Yue United States 15 275 0.8× 141 0.8× 97 0.8× 50 0.5× 45 0.4× 28 638
Maryann Kaler United States 13 373 1.1× 133 0.8× 209 1.8× 120 1.1× 30 0.3× 19 706
Seth B. Furgeson United States 15 512 1.5× 116 0.7× 126 1.1× 141 1.3× 67 0.7× 30 953
Qun Liu China 15 234 0.7× 122 0.7× 39 0.3× 163 1.5× 41 0.4× 41 687
Binggang Xiang United States 11 360 1.0× 42 0.2× 243 2.1× 75 0.7× 58 0.6× 14 843

Countries citing papers authored by Chuangyan Wu

Since Specialization
Citations

This map shows the geographic impact of Chuangyan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuangyan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuangyan Wu more than expected).

Fields of papers citing papers by Chuangyan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuangyan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuangyan Wu. The network helps show where Chuangyan Wu may publish in the future.

Co-authorship network of co-authors of Chuangyan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chuangyan Wu. A scholar is included among the top collaborators of Chuangyan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuangyan Wu. Chuangyan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Wu, Chuangyan, Xiangyu Luo, Xueying Wang, et al.. (2024). Down-regulation of KLRB1 is associated with increased cell growth, metastasis, poor prognosis, as well as a dysfunctional immune microenvironment in LUAD. Scientific Reports. 14(1). 11782–11782. 3 indexed citations
5.
Tong, Song, Sihua Wang, Chuangyan Wu, et al.. (2023). The effects of the prognostic biomarker SAAL1 on cancer growth and its association with the immune microenvironment in lung adenocarcinoma. BMC Cancer. 23(1). 275–275. 6 indexed citations
6.
Guo, Qiang, et al.. (2022). The Roles and Mechanisms of TRAT1 in the Progression of Non-Small Cell Lung Cancer. Current Medical Science. 42(6). 1186–1200. 8 indexed citations
7.
Guo, Qiang, Song Tong, Chuangyan Wu, et al.. (2022). TRAT1 overexpression delays cancer progression and is associated with immune infiltration in lung adenocarcinoma. Frontiers in Oncology. 12. 960866–960866. 7 indexed citations
8.
Ding, Xiangchao, Sheng Le, Yunshu Su, et al.. (2022). Cytosporone B (Csn-B), an NR4A1 agonist, attenuates acute cardiac allograft rejection by inducing differential apoptosis of CD4+T cells. International Immunopharmacology. 104. 108521–108521. 4 indexed citations
9.
Ding, Xiangchao, Dan Cheng, Bing Sun, et al.. (2022). Nomogram and risk calculator for severe hypoxemia after heart valve surgery. Frontiers in Cardiovascular Medicine. 9. 972449–972449. 2 indexed citations
10.
Guo, Qiang, Chuangyan Wu, Dan Li, et al.. (2022). Clinical Roles of Risk Model Based on Differentially Expressed Genes in Mesenchymal Stem Cells in Prognosis and Immunity of Non-small Cell Lung Cancer. Frontiers in Genetics. 13. 823075–823075. 10 indexed citations
12.
Wu, Weixiang, et al.. (2020). Association between phthalate exposure and asthma risk: A meta-analysis of observational studies. International Journal of Hygiene and Environmental Health. 228. 113539–113539. 31 indexed citations
13.
Huang, Yajun, Sufei Wang, Xiangchao Ding, et al.. (2020). Inhibition of S-adenosyl-L-homocysteine hydrolase alleviates alloimmune response by down-regulating CD4+ T-cell activation in a mouse heart transplantation model. Annals of Translational Medicine. 8(23). 1582–1582. 8 indexed citations
14.
Tong, Song, Su Yuan, Yu Yuan, et al.. (2020). Ribavirin therapy for severe COVID-19: a retrospective cohort study. International Journal of Antimicrobial Agents. 56(3). 106114–106114. 121 indexed citations
15.
Chen, Shanshan, Yuanyuan Zhao, Jinbao Huang, et al.. (2019). TROVE2 strengthens the anti-inflammatory effect via macrophage polarization by estrogen induction in abdominal aortic aneurysm. Life Sciences. 242. 117207–117207. 6 indexed citations
16.
Wu, Chuangyan, et al.. (2018). The selective Nlrp3 inflammasome inhibitor Mcc950 attenuates lung ischemia-reperfusion injury. Biochemical and Biophysical Research Communications. 503(4). 3031–3037. 59 indexed citations
17.
Wang, Ke, Peng Deng, Yuan Sun, et al.. (2018). MicroRNA-155 promotes neointimal hyperplasia through smooth muscle-like cell-derived RANTES in arteriovenous fistulas. Journal of Vascular Surgery. 67(3). 933–944.e3. 7 indexed citations
18.
Xiang, Mei, Hongbo R. Luo, Jia Wu, et al.. (2018). ADAM23 in Cardiomyocyte Inhibits Cardiac Hypertrophy by Targeting FAK‐AKT Signaling. Journal of the American Heart Association. 7(18). e008604–e008604. 18 indexed citations
20.
Zhang, Anchen, Ke Wang, Cheng Zhou, et al.. (2016). Knockout of microRNA-155 ameliorates the Th1/Th17 immune response and tissue injury in chronic rejection. The Journal of Heart and Lung Transplantation. 36(2). 175–184. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026